The pill bottle is opened. Three students circle around several lines of a crushed yellow substance. The occasion is a late-night study session, the drug of choice: Adderall. This fictional story is a sad reality, deeply rooted in the circuits of higher education. College campuses are home to an outbreak of prescription drug abuse. A strong foundation of overly prescribed stimulants, combined with the high educational demands of classes, poses a major problem for universities. Not only have studies been carried out proving the abuse of psychostimulant medications dangerous to the health of students, but the transactions behind such abuse are highly illegal. It is an ethical question framed by a society's willingness to accept or abuse pills and how often doctors are willing to prescribe drugs. Psychostimulants began to be used to treat ADHD in the 1930s, when they were first observed to have positive effects on hyperactivity. activity. It was later synthesized as Ritalin in 1957. It was prescribed to people with attention and hyperactivity problems and is still prescribed today. Early stimulants were transformed into amphetamine/lisdexamphetamine in drugs such as Adderall and Vyvanse. In recent years, prescription rates for stimulants have increased, leading to a national and academic problem. Adderall is a concentration drug, and higher education demands student concentration more than anything. This is a recipe for disaster that is about to escalate if action is not taken to put an end to this problem. This problem is morally unacceptable. Ethics requires that universities establish some sort of education system about drugs of abuse in order to raise awareness of the health implications that this... middle of article ......ications Co. , nd Web. April 24, 2014. Ricker, Ronald and Venus Nicolino. “Adderall: America’s Most Abused Drug.” The Huffington Post. TheHuffingtonPost.com Inc, June 21, 2010. Web. April 23, 2014. .Schwarz, Alan. “ADHD seen in 11% of U.S. children as diagnoses increase.” . The New York Times Company, March 13, 2013. Web. April 25, 2014. .Schwarz, Alan. “Risky rise of good quality pill.” The New York Times. The New York Times Company, June 9, 2012. Web. April 23 2014. .